Named Entity Recognition on BioNLP13CG (test)
69.7F1 ScoreUnified-00
Evaluation results
| Method | Links | ||||||
|---|---|---|---|---|---|---|---|
| Unified-00Supervision=no-supervision, Training Source=Other Biomedical Datasets2019.09 | 69.7 | 68.1 | 71.5 | — | — | — | |
| Unified-11Supervision=no-supervision, Training Source=Other Biomedical Datasets2019.09 | 67.7 | 64 | 71.9 | — | — | — | |
| MTM-VoteSupervision=no-supervision, Training Source=Other Biomedical Datasets2019.09 | 61 | 56.7 | 65.9 | — | — | — | |
| Unified-01Supervision=no-supervision, Training Source=Other Biomedical Datasets2019.09 | 37.5 | 72.5 | 25.3 | — | — | — | |
| SciSpaCyEntities=16 types in Cancer Genetics, Model=scispacy-medium2020.11 | — | — | — | 77.6 | — | — | |
| Single (QA)Averaged over 10 runs=true, Measurement=One epoch2023.10 | — | — | — | — | 1,372.8 | 323.3 | |
| Single(SeqTag)Averaged over 10 runs=true, Measurement=One epoch2023.10 | — | — | — | — | 102.2 | 25.2 | |
| Spark - BiomedicalEntities=16 types in Cancer Genetics, Embeddings=Domain specific (Biomedical)2020.11 | — | — | — | 85.58 | — | — | |
| Spark - GloVe 6BEntities=16 types in Cancer Genetics, Embeddings=General purpose (GloVe 6B)2020.11 | — | — | — | 84.3 | — | — | |
| SplitNER(QA-QA)Averaged over 10 runs=true, Measurement=One epoch2023.10 | — | — | — | — | 241.2 | 57.7 | |
| StanzaEntities=16 types in Cancer Genetics2020.11 | — | — | — | 84.34 | — | — |